Recombinant Human CD79B (C-6His)

Description

EnkiLife provides the Recombinant Human CD79B (C-6His) protein,aslo know as B-Cell Antigen Receptor Complex-Associated Protein Beta Chain,B-Cell-Specific Glycoprotein B29,Ig-Beta,Immunoglobulin-Associated B29 Protein,CD79b,CD79B,B29,IGB, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human CD79B is produced by our Mammalian expression system and the target gene encoding Ala29-Asp159 is expressed with a 6His tag at the C-terminus.Accession:P40259. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:16.25 KDa. Background:CD79B is a single-pass type I membrane protein. CD79B contains one Ig-like V-type domain and one ITAM domain. CD79B is required in cooperation with CD79A for initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR), which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. CD79B enhances phosphorylation of CD79A, possibly by recruiting kinases that phosphorylate CD79A or by recruiting proteins that bind to CD79A and protect it from dephosphorylation.